As Wpx Energy (WPX) Market Value Rose, Encompass Capital Advisors Trimmed Position; Healthcor Management LP Holding in Neurocrine Biosciences (NBIX) Has Cut by $43.28 Million as Valuation Rose

April 22, 2018 - By Larry Anderson

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Logo

Arthur B Cohen decreased its stake in Neurocrine Biosciences Inc (NBIX) by 26.93% based on its latest 2017Q4 regulatory filing with the SEC. Healthcor Management Lp sold 562,110 shares as the company’s stock rose 13.16% while stock markets declined. The hedge fund run by Arthur B Cohen held 1.53 million shares of the health care company at the end of 2017Q4, valued at $118.33 million, down from 2.09M at the end of the previous reported quarter. Healthcor Management Lp who had been investing in Neurocrine Biosciences Inc for a number of months, seems to be less bullish one the $7.14 billion market cap company. The stock increased 1.56% or $1.22 during the last trading session, reaching $79.4. About 523,000 shares traded. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) has risen 91.92% since April 22, 2017 and is uptrending. It has outperformed by 80.37% the S&P500.

Todd J. Kantor decreased its stake in Wpx Energy Inc (WPX) by 32.33% based on its latest 2017Q4 regulatory filing with the SEC. Encompass Capital Advisors Llc sold 1.68 million shares as the company’s stock rose 0.29% while stock markets declined. The hedge fund run by Todd J. Kantor held 3.51 million shares of the energy company at the end of 2017Q4, valued at $49.39M, down from 5.19M at the end of the previous reported quarter. Encompass Capital Advisors Llc who had been investing in Wpx Energy Inc for a number of months, seems to be less bullish one the $6.66 billion market cap company. The stock increased 0.97% or $0.16 during the last trading session, reaching $16.68. About 7.15M shares traded. WPX Energy, Inc. (NYSE:WPX) has risen 11.34% since April 22, 2017 and is uptrending. It has underperformed by 0.21% the S&P500.

Encompass Capital Advisors Llc, which manages about $1.18B and $704.21M US Long portfolio, upped its stake in Southwestern Energy Co (NYSE:SWN) by 862,553 shares to 8.80 million shares, valued at $49.10 million in 2017Q4, according to the filing. It also increased its holding in Gulfport Energy Corp (NASDAQ:GPOR) by 618,793 shares in the quarter, for a total of 4.48 million shares, and has risen its stake in Ring Energy Inc (NYSEMKT:REI).

Analysts await WPX Energy, Inc. (NYSE:WPX) to report earnings on May, 2 after the close. They expect $-0.02 earnings per share, up 86.67% or $0.13 from last year’s $-0.15 per share. After $-0.02 actual earnings per share reported by WPX Energy, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Among 33 analysts covering WPX Energy (NYSE:WPX), 30 have Buy rating, 0 Sell and 3 Hold. Therefore 91% are positive. WPX Energy had 123 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Piper Jaffray with “Buy” on Wednesday, April 18. Seaport Global upgraded WPX Energy, Inc. (NYSE:WPX) on Tuesday, December 19 to “Neutral” rating. The rating was upgraded by Cowen & Co to “Outperform” on Thursday, June 22. The stock has “Buy” rating by Northland Capital on Tuesday, February 6. UBS initiated the shares of WPX in report on Thursday, March 23 with “Buy” rating. The firm earned “Sell” rating on Wednesday, June 21 by Seaport Global. The firm has “Overweight” rating by Barclays Capital given on Tuesday, November 7. BMO Capital Markets maintained WPX Energy, Inc. (NYSE:WPX) rating on Sunday, August 27. BMO Capital Markets has “Buy” rating and $13.0 target. The stock of WPX Energy, Inc. (NYSE:WPX) has “Buy” rating given on Monday, February 26 by Northland Capital. Northland Capital maintained the shares of WPX in report on Monday, August 21 with “Buy” rating.

Investors sentiment decreased to 1.04 in Q4 2017. Its down 0.25, from 1.29 in 2017Q3. It dropped, as 32 investors sold WPX shares while 105 reduced holdings. 57 funds opened positions while 85 raised stakes. 381.83 million shares or 0.86% less from 385.12 million shares in 2017Q3 were reported. Huntington State Bank holds 0% of its portfolio in WPX Energy, Inc. (NYSE:WPX) for 100 shares. Metropolitan Life Comm Ny accumulated 113,911 shares. Ny State Teachers Retirement System accumulated 372,610 shares. Ameritas Partners reported 119,329 shares. Putnam Invests Lc holds 0% or 131,656 shares. Tctc Holdings Ltd Liability Corp reported 313,193 shares stake. Voya Inv Mgmt Ltd Liability Co accumulated 106,784 shares. Salem Investment Counselors stated it has 100 shares or 0% of all its holdings. Mitchell Gp, a Texas-based fund reported 1.74 million shares. Moreover, Shapiro Capital Mngmt Limited Company has 4.06% invested in WPX Energy, Inc. (NYSE:WPX). Pnc Fin holds 0% in WPX Energy, Inc. (NYSE:WPX) or 22,582 shares. Cushing Asset Mgmt LP accumulated 66,000 shares. Legal General Grp Public Limited Com reported 568,453 shares or 0.01% of all its holdings. Tiaa Cref Investment Limited Liability Com reported 4.30 million shares. State Of Wisconsin Investment Board stated it has 81,262 shares.

Investors sentiment decreased to 1.31 in 2017 Q4. Its down 0.35, from 1.66 in 2017Q3. It dropped, as 18 investors sold NBIX shares while 76 reduced holdings. 58 funds opened positions while 65 raised stakes. 91.25 million shares or 1.56% less from 92.69 million shares in 2017Q3 were reported. Millennium Mgmt Ltd Liability Corporation owns 534,566 shares. D E Shaw & reported 0.01% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Nelson Van Denburg & Campbell Wealth Mgmt Grp Incorporated Ltd Com reported 1,120 shares stake. Jefferies Gru Ltd Liability Corp has 0% invested in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Blackrock invested in 0.02% or 4.78 million shares. 56,583 were reported by Voya Invest Mngmt Limited Com. Van Eck stated it has 129,395 shares. First Republic Investment Mgmt owns 0.01% invested in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) for 23,611 shares. Swiss National Bank & Trust, a Switzerland-based fund reported 150,200 shares. Parkside Bankshares Tru has invested 0% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). The Illinois-based Castleark Mngmt Limited Liability Com has invested 0.07% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). 251,763 were reported by Thrivent For Lutherans. Massachusetts Serv Ma has 108,635 shares for 0% of their portfolio. Parallax Volatility Advisers Lp stated it has 2,091 shares. Pub Employees Retirement Association Of Colorado holds 178,399 shares or 0.09% of its portfolio.

Healthcor Management Lp, which manages about $3.20B and $3.07B US Long portfolio, upped its stake in Humana Inc (NYSE:HUM) by 2,570 shares to 263,440 shares, valued at $65.35 million in 2017Q4, according to the filing. It also increased its holding in Zimmer Biomet Hldgs Inc (ZMH) by 1.28 million shares in the quarter, for a total of 1.53M shares, and has risen its stake in Clovis Oncology Inc (NASDAQ:CLVS).

Among 13 analysts covering Neurocrine Biosci (NASDAQ:NBIX), 13 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Neurocrine Biosci had 54 analyst reports since August 18, 2015 according to SRatingsIntel. The rating was initiated by BMO Capital Markets with “Outperform” on Thursday, April 7. The rating was maintained by Robert W. Baird with “Buy” on Thursday, September 21. Leerink Swann maintained the stock with “Outperform” rating in Thursday, November 2 report. BMO Capital Markets maintained the shares of NBIX in report on Tuesday, October 3 with “Buy” rating. The rating was maintained by Oppenheimer on Thursday, February 22 with “Buy”. The stock has “Buy” rating by Deutsche Bank on Thursday, November 2. The rating was maintained by Jefferies with “Buy” on Monday, September 4. On Friday, August 4 the stock rating was maintained by Cowen & Co with “Buy”. As per Tuesday, November 22, the company rating was initiated by Oppenheimer. Piper Jaffray maintained it with “Buy” rating and $96.0 target in Monday, January 8 report.

Analysts await Neurocrine Biosciences, Inc. (NASDAQ:NBIX) to report earnings on May, 8. They expect $-0.32 earnings per share, up 64.44% or $0.58 from last year’s $-0.9 per share. After $0.07 actual earnings per share reported by Neurocrine Biosciences, Inc. for the previous quarter, Wall Street now forecasts -557.14% negative EPS growth.

Since January 2, 2018, it had 0 insider purchases, and 22 selling transactions for $29.59 million activity. RASTETTER WILLIAM H sold $855,000 worth of stock. The insider Lippoldt Darin sold $157,053. On Friday, February 9 Grigoriadis Dimitri E. sold $6.76M worth of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) or 86,368 shares. LYONS GARY A had sold 5,000 shares worth $423,341 on Thursday, February 15. On Monday, March 5 Gano Kyle sold $2.13M worth of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) or 23,650 shares. $128,575 worth of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was sold by Bozigian Haig P..

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: